IMB Dx, Inc. (KOSDAQ:461030)
South Korea · Delayed Price · Currency is KRW 10,400
-500 (-4.59%)
Sep 19, 2025, 3:30 PM KST
IMB Dx Market Cap
IMB Dx has a market cap or net worth of 145.78 billion as of September 19, 2025. Its market cap has decreased by -47.42% in one year.
Market Cap
145.78B
Enterprise Value
121.55B
Revenue
3.83B
Ranking
n/a
PE Ratio
n/a
Stock Price
10,400.00
Market Cap Chart
Since April 3, 2024, IMB Dx's market cap has decreased from 503.73B to 145.78B, a decrease of -71.06%. That is a compound annual growth rate of -57.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 145.78B | -2.35% |
| Dec 30, 2024 | 149.29B | -70.36% |
| Apr 3, 2024 | 503.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.24T |
| Celltrion | 37.12T |
| ALTEOGEN | 25.30T |
| Yuhan | 8,752.85B |
| SK Biopharmaceuticals | 8,450.00B |
| Peptron | 6,744.58B |
| PharmaResearch | 6,316.91B |
| ABL Bio | 5,473.88B |